Oak Ridge Investments LLC Has $21.22 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Oak Ridge Investments LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 41,946 shares of the healthcare conglomerate's stock after acquiring an additional 2,227 shares during the period. UnitedHealth Group accounts for 1.7% of Oak Ridge Investments LLC's portfolio, making the stock its 11th biggest holding. Oak Ridge Investments LLC's holdings in UnitedHealth Group were worth $21,219,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the third quarter valued at about $27,000. Global Wealth Strategies & Associates lifted its stake in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at approximately $32,000. Quarry LP lifted its holdings in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock valued at $33,000 after acquiring an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the third quarter valued at approximately $37,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $0.56 during mid-day trading on Friday, reaching $510.03. The company had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The company has a 50 day moving average of $549.37 and a 200-day moving average of $563.18. The firm has a market cap of $469.38 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company earned $5.83 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Truist Financial cut their price objective on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. KeyCorp reiterated an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday. Bank of America dropped their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a research note on Wednesday, October 16th. Morgan Stanley cut their price target on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research note on Wednesday, October 16th. Finally, Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a research report on Thursday, December 5th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Buy" and a consensus price target of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.